SEC Form D private-offering filing
PharmassetX Inc.
A new SEC Form D private-offering notice from Louisville, KY, a $6,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage pharmaceutical company developing an EGCG based drug candidate for inflammatory bowel disease, including pouchitis.
Filed 2026-05-04Filed to raise $6,000,000First money in 2026-04-30Raised so far $100,000HQ (as filed) Louisville, KYSector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified pharmassetx.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.